Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Working Capital to Net Assets Ratio
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Working Capital to Net Assets ratio of 2678.5% as of March 2026. Working capital of $1.07 Billion (current assets of $1.80 Billion minus current liabilities of $728.05 Million) is measured against net assets of $39.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Amneal Pharmaceuticals, Inc. Class A Com balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Amneal Pharmaceuticals, Inc. Class A Common Stock Working Capital to Net Assets (2015–2025)
This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 2678.5%, reflecting working capital of $1.07 Billion against net assets of $39.94 Million USD. Check Amneal Pharmaceuticals, Inc. Class A Com tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see AMRX company net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17265.6% | $1.03 Billion | $5.96 Million | $1.91 Billion | $881.63 Million | ▲ +18294.0 pp |
| 2024 | -1028.4% | $458.04 Million | $-44.54 Million | $1.59 Billion | $1.13 Billion | ▼ -1895.0 pp |
| 2023 | 866.6% | $531.27 Million | $61.30 Million | $1.38 Billion | $846.60 Million | ▲ +551.2 pp |
| 2022 | 315.4% | $659.02 Million | $208.93 Million | $1.41 Billion | $752.80 Million | ▲ +85.7 pp |
| 2021 | 229.7% | $842.87 Million | $366.97 Million | $1.52 Billion | $677.24 Million | ▼ -15.5 pp |
| 2020 | 245.2% | $874.64 Million | $356.74 Million | $1.55 Billion | $676.90 Million | ▲ +54.9 pp |
| 2019 | 190.3% | $659.80 Million | $346.79 Million | $1.21 Billion | $550.41 Million | ▲ +108.5 pp |
| 2018 | 81.8% | $732.79 Million | $896.36 Million | $1.29 Billion | $553.85 Million | ▲ +208.2 pp |
| 2017 | -126.5% | $475.05 Million | $-375.58 Million | $771.93 Million | $296.88 Million | ▲ +158.3 pp |
| 2016 | -284.8% | $501.04 Million | $-175.94 Million | $726.11 Million | $225.07 Million | ▼ -89.2 pp |
| 2015 | -195.6% | $365.45 Million | $-186.87 Million | $604.60 Million | $239.15 Million | — |